PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 116 filers reported holding PMV PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,085,936 | +3.9% | 339,729 | +5.9% | 0.00% | – |
| Q2 2023 | $2,008,196 | +36.5% | 320,798 | +4.0% | 0.00% | – |
| Q1 2023 | $1,471,574 | -47.3% | 308,506 | -3.8% | 0.00% | -100.0% |
| Q4 2022 | $2,790,377 | -25.9% | 320,733 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $3,767,000 | -15.6% | 316,518 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $4,462,000 | -12.8% | 313,137 | +27.4% | 0.00% | 0.0% |
| Q1 2022 | $5,116,000 | -11.2% | 245,758 | -1.4% | 0.00% | 0.0% |
| Q4 2021 | $5,759,000 | -23.6% | 249,293 | -1.5% | 0.00% | 0.0% |
| Q3 2021 | $7,541,000 | -14.9% | 253,076 | -2.5% | 0.00% | -50.0% |
| Q2 2021 | $8,866,000 | +66.6% | 259,515 | +60.4% | 0.00% | +100.0% |
| Q1 2021 | $5,323,000 | -44.6% | 161,827 | +3.6% | 0.00% | -50.0% |
| Q4 2020 | $9,612,000 | +1595.2% | 156,278 | +878.1% | 0.00% | – |
| Q3 2020 | $567,000 | – | 15,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |